stoxline Quote Chart Rank Option Currency Glossary
Zymergen Inc. (ZY)
2.43  0 (0%)    10-18 16:00
Open: 2.51
High: 2.58
Volume: 2,350,912
Pre. Close: 2.43
Low: 2.335
Market Cap: 0(M)
Technical analysis
2022-11-18 4:26:41 PM
Short term     
Mid term     
Targets 6-month :  2.95 1-year :  3.11
Resists First :  2.52 Second :  2.67
Pivot price 2.43
Supports First :  2.29 Second :  1.91
MAs MA(5) :  2.43 MA(20) :  2.43
MA(100) :  2.43 MA(250) :  3.23
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  38.7 D(3) :  38.7
RSI RSI(14): 43.9
52-week High :  9.78 Low :  1.1
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ZY ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.59 - 2.6 2.6 - 2.61
Low: 2.3 - 2.32 2.32 - 2.33
Close: 2.41 - 2.43 2.43 - 2.45
Company Description

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

Headline News

Wed, 19 Oct 2022
Ginkgo Bioworks Completes Acquisition of Zymergen - PR Newswire

Tue, 06 Sep 2022
Zymergen's problems were evident to board shortly after IPO, SEC filings show - The Business Journals

Tue, 26 Jul 2022
Zymergen Stock: Upcoming Ginkgo Bioworks Acquisition (NASDAQ:ZY) - Seeking Alpha

Fri, 18 Feb 2022
6 Penny Stocks To Buy For Under $5 With Unusual Options Activity - Penny Stocks

Wed, 08 Sep 2021
Why Shares of Zymergen Plunged 62% in August - The Motley Fool

Thu, 05 Aug 2021
Zymergen Announces Executive Appointments, Strengthening Leadership Team in Key Areas - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Basic Materials
Chemicals - Specialty
Shares Out 0 (M)
Shares Float 102 (M)
Held by Insiders 5.353e+007 (%)
Held by Institutions 7.6 (%)
Shares Short 5,520 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.7642e+008
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 675.3 %
Return on Equity (ttm) -44.1 %
Qtrly Rev. Growth 1.78e+007 %
Gross Profit (p.s.) -1.59
Sales Per Share 0.19
EBITDA (p.s.) -2.93
Qtrly Earnings Growth -7 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -264 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio -0.1
Price to Book value 0
Price to Sales 12.68
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 3.41e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android